Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T14:40:53.397Z.
Calculation as of: 2026-10-06T14:40:53.397Z.
Quote observation: 2026-10-06T14:39:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c64da899843448fde498cf5e629ee28b7cf55c7878198a0aebccb75d14602d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aspire Biopharma Holdings, Inc.
Market Cap
$1.03M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$898311.00
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.18M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$869976.00
EV/EBITDA Ratio
N/A
TTM Avg
1464.50x
3Y Avg
6462.34x
5Y Avg
6462.34x
Market Cap
$844393.00
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$838015.00
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.03M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $898311.00 | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | N/A | 18.93x | 18.93x | 18.93x |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $869976.00 | N/A | 1464.50x | 6462.34x | 6462.34x |
| Decoy Therapeutics Inc. (DCOY)vs › | $844393.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838015.00 | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.33M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-08-13 | 1.51x |
| 2026-08-12 | 1.51x |
| 2026-08-11 | 1.69x |
| 2026-08-10 | 1.75x |
| 2026-08-07 | 1.73x |
| 2026-08-06 | 1.49x |
| 2026-08-05 | 1.56x |
| 2026-08-04 | 1.48x |
| 2026-08-03 | 1.55x |
| 2026-07-31 | 1.29x |
| 2026-07-30 | 1.37x |
| 2026-07-29 | 0.97x |
| 2026-07-28 | 1.56x |
| 2026-07-27 | 1.46x |
| 2026-07-24 | 1.56x |
| 2026-07-23 | 1.54x |
| 2026-07-22 | 1.74x |
| 2026-07-21 | 1.66x |
| 2026-07-20 | 1.32x |
| 2026-07-17 | 1.19x |
| 2026-07-16 | 1.21x |
| 2026-07-15 | 1.12x |
| 2026-07-14 | 1.12x |
| 2026-07-13 | 1.10x |
| 2026-07-10 | 1.11x |
| 2026-07-09 | 1.13x |
| 2026-07-08 | 1.03x |
| 2026-07-07 | 0.97x |
| 2026-07-06 | 1.06x |
| 2026-07-02 | 1.18x |
| 2026-07-01 | 1.06x |
| 2026-06-30 | 0.87x |
| 2026-06-29 | 1.16x |
| 2026-06-26 | 1.11x |
| 2026-06-25 | 1.27x |
| 2026-06-24 | 1.30x |
| 2026-06-23 | 1.17x |
| 2026-06-22 | 1.21x |
| 2026-06-18 | 1.32x |
| 2026-06-17 | 1.24x |
| 2026-06-16 | 1.18x |
| 2026-06-15 | 0.98x |
| 2026-06-12 | 0.73x |
| 2026-06-11 | 1.11x |
| 2026-06-10 | 0.97x |
| 2026-06-09 | 1.10x |
| 2026-06-08 | 1.34x |
| 2026-06-05 | 0.87x |
| 2026-06-04 | 1.13x |
| 2026-06-03 | 1.05x |
| 2026-06-02 | 1.12x |
| 2026-06-01 | 1.09x |
| 2026-05-29 | 0.92x |
| 2026-05-28 | 0.94x |
| 2026-05-27 | 0.63x |
| 2026-05-26 | 0.77x |
| 2026-05-22 | 0.90x |
| 2026-05-21 | 0.96x |
| 2026-05-20 | 1.12x |
| 2026-05-19 | 1.05x |
| 2026-05-18 | 1.35x |
